Consensus report from the Miami liver proton therapy conference

Michael D. Chuong, Adeel Kaiser, Fazal Khan, Parag Parikh, Edgar Ben-Josef, Christopher Crane, Thomas Brunner, Toshiyuki Okumura, Niek Schreuder, Søren M. Bentzen, Alonso Gutierrez, Alejandra Mendez Romero, Sang Min Yoon, Navesh Sharma, Tae Hyun Kim, Kazushi Kishi, Fred Moeslein, Sarah Hoffe, Tracey Schefter, Steven HanishMarta Scorsetti, Smith Apisarnthanarax

Research output: Contribution to journalReview article

Abstract

An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.

Original languageEnglish (US)
Article number00457
JournalFrontiers in Oncology
Volume9
Issue numberMAY
DOIs
Publication statusPublished - Jan 1 2019
Externally publishedYes

    Fingerprint

Keywords

  • Cholangiocarcinoma (CC)
  • Hepatocellular carcinoma (HCC)
  • Liver cancer
  • Liver metastases
  • Proton therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Chuong, M. D., Kaiser, A., Khan, F., Parikh, P., Ben-Josef, E., Crane, C., ... Apisarnthanarax, S. (2019). Consensus report from the Miami liver proton therapy conference. Frontiers in Oncology, 9(MAY), [00457]. https://doi.org/10.3389/fonc.2019.00457